Clinical Trials Logo

Clinical Trial Summary

To compare the rate and extent of absorption of cabergoline 0.5 mg tablets (test) versus Dostinex (reference)


Clinical Trial Description

To compare the rate and extent of absorption of cabergoline 0.5 mg tablets (test) versus Dostinex (reference) administered as 2 x 0.5 mg tablets under fasting conditions. ;


Study Design

Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label


Related Conditions & MeSH terms

  • Disease
  • To Determine Bioequivalence Under Fasting Conditions

NCT number NCT00653055
Study type Interventional
Source Par Pharmaceutical, Inc.
Contact
Status Completed
Phase Phase 1
Start date August 2001
Completion date December 2001

See also
  Status Clinical Trial Phase
Completed NCT00653380 - Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions Phase 1
Completed NCT00653120 - Bioavailability Study of Propranolol Under Fasting Conditions Phase 2
Completed NCT00653315 - Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions Phase 1
Completed NCT00652912 - Bioavailability Study of Clonazepam ODT Under Fasting Conditions Phase 1
Completed NCT00653419 - Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions Phase 1
Completed NCT00652795 - Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions Phase 1
Completed NCT01380457 - Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions Phase 1
Completed NCT01380483 - Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions Phase 1
Completed NCT00652639 - Bioavailability Study of Clonazepam Tablets Under Fasting Conditions Phase 1
Completed NCT00653549 - Bioavailability Study of Torsemide Tablets Under Fasting Conditions Phase 1